Literature DB >> 24980143

The neuroprotective effects of α-iso-cubebene on dopaminergic cell death: involvement of CREB/Nrf2 signaling.

Sun Young Park1, Beung Gu Son, Young Hoon Park, Cheol-Min Kim, Geuntae Park, Young-Whan Choi.   

Abstract

As a part of ongoing studies to elucidate pharmacologically active components of Schisandra chinensis, we isolated and studied α-iso-cubebene. The neuroprotective mechanisms of α-iso-cubebene in human neuroblastoma SH-SY5Y cells were investigated. α-Iso-cubebene significantly inhibited cytotoxicity and apoptosis due to 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in dopaminergic SH-SY5Y cells. Pretreatment of cells with α-iso-cubebene reduced intracellular accumulation of ROS and calcium in response to 6-OHDA. The neuroprotective effects of α-iso-cubebene were found to result from protecting the mitochondrial membrane potential. Notably, α-iso-cubebene inhibited the release of apoptosis-inducing factor from the mitochondria into the cytosol and nucleus after 6-OHDA treatment. α-Iso-cubebene also induced the activation of PKA/PKB/CREB/Nrf2 and suppressed 6-OHDA-induced neurotoxicity. α-Iso-cubebene was found to induce phosphorylation of PKA and PKB and activate Nrf2 and CREB signaling pathways in a dose-dependent manner. Additionally, α-iso-cubebene stimulated the expression of the antioxidant response genes NQO1 and HO-1. Finally, α-iso-cubebene-mediated neuroprotective effects were found to be reversible after transfection with CREB and Nrf2 small interfering RNAs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24980143     DOI: 10.1007/s11064-014-1371-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

Review 1.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

2.  AIF-mediated mitochondrial pathway is critical for the protective effect of diazoxide against SH-SY5Y cell apoptosis.

Authors:  Hong Zhang; Zhan-Qiang Wang; Dan-Yang Zhao; Dong-Ming Zheng; Juan Feng; Li-Chun Song; Yumin Luo
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

3.  Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival.

Authors:  Junghee Lee; Chun-Hyung Kim; David K Simon; Lyaylya R Aminova; Alexander Y Andreyev; Yulia E Kushnareva; Anne N Murphy; Bonnie E Lonze; Kwang-Soo Kim; David D Ginty; Robert J Ferrante; Hoon Ryu; Rajiv R Ratan
Journal:  J Biol Chem       Date:  2005-10-05       Impact factor: 5.157

Review 4.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

5.  Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization.

Authors:  Yumiko Kawai; Lakisha Garduño; Melanie Theodore; Jianqi Yang; Ifeanyi J Arinze
Journal:  J Biol Chem       Date:  2010-12-31       Impact factor: 5.157

6.  Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1.

Authors:  Paul S Baxter; Marc-Andre Martel; Aoife McMahon; Peter C Kind; Giles E Hardingham
Journal:  J Neurochem       Date:  2011-06-17       Impact factor: 5.372

7.  Mitochondrial contribution to Parkinson's disease pathogenesis.

Authors:  Anthony H V Schapira; Matthew Gegg
Journal:  Parkinsons Dis       Date:  2011-04-28

8.  Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.

Authors:  Kazuhiro Nakaso; Satoru Ito; Kenji Nakashima
Journal:  Neurosci Lett       Date:  2007-12-23       Impact factor: 3.046

Review 9.  Potential role of CREB as a prognostic marker in acute myeloid leukemia.

Authors:  Jerry C Cheng; Samuel Esparza; Salemiz Sandoval; Deepa Shankar; Cecilia Fu; Kathleen M Sakamoto
Journal:  Future Oncol       Date:  2007-08       Impact factor: 3.404

10.  Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.

Authors:  Steven P Presgraves; Tariq Ahmed; Sabine Borwege; Jeffrey N Joyce
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.978

View more
  4 in total

Review 1.  Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review.

Authors:  Ramu Venkatesan; Eunhee Ji; Sun Yeou Kim
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

Review 2.  Neuroprotective and Cognitive Enhancement Potentials of Angelica gigas Nakai Root: A Review.

Authors:  Kandhasamy Sowndhararajan; Songmun Kim
Journal:  Sci Pharm       Date:  2017-04-28

Review 3.  Schisandra chinensis Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological Diseases.

Authors:  Minyu Zhang; Liping Xu; Hongjun Yang
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

4.  Preparation of an Antimicrobial and Antioxidant Bio-Polymer Film and Its Application as Glazing Shell for Postharvest Quality of Fresh-Cut Apple.

Authors:  Zhaohui Yang; Yalan Zhang; Yihui Zhao; Hao Dong; Jian Peng; Qi He
Journal:  Foods       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.